Brief: Immunovia Q1 Pretax Loss Narrows To SEK 23.4 Million
April 28 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA REPORTS INTERIM REPORT JANUARY - MARCH 2021
* Q1 PRETAX LOSS SEK 23.4 MILLION VERSUS LOSS SEK 27.8
MILLION
YEAR AGO
* Q1 NET SALES SEK 123 MLN VS SEK 14 MLN YR AGO
Source text for Eikon: ID:nWkr1vyLcG
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study